Cooley advised Unchained Labs on its agreement to sell to The Carlyle Group, a publicly traded global investment firm, for $435 million. Partners Mark Weeks, Anne Lieberman and Al Browne led the Cooley team advising Unchained Labs, a life sciences tools company focused on solving problems for biologics and gene therapy researchers.
Read more